229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-33.37%
Negative revenue growth while VUZI stands at 54.16%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-34.52%
Negative gross profit growth while VUZI is at 47.29%. Joel Greenblatt would examine cost competitiveness or demand decline.
-42.13%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-42.13%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-42.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-42.17%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-42.68%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.80%
Share reduction while VUZI is at 0.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.95%
Reduced diluted shares while VUZI is at 0.22%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.47%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-57.76%
Negative OCF growth while VUZI is at 1.18%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-61.62%
Negative FCF growth while VUZI is at 0.79%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1138.07%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
140.19%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
38.30%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
10006.86%
Positive long-term OCF/share growth while VUZI is negative. John Neff would see a structural advantage in sustained cash generation.
118.61%
Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.
10.66%
Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.
2637.90%
Net income/share CAGR above 1.5x VUZI's 28.12% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
105.84%
5Y net income/share CAGR above 1.5x VUZI's 3.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
31.38%
3Y net income/share CAGR 50-75% of VUZI's 45.90%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
1503.98%
Equity/share CAGR of 1503.98% while VUZI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
148.69%
5Y equity/share CAGR is in line with VUZI's 141.74%. Walter Schloss would see parallel mid-term profitability and retention policies.
14.85%
Below 50% of VUZI's 122.24%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.96%
3Y dividend/share CAGR of 38.96% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.59%
Firm’s AR is declining while VUZI shows 80.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.94%
Inventory is declining while VUZI stands at 1.90%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.09%
Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.53%
Positive BV/share change while VUZI is negative. John Neff sees a clear edge over a competitor losing equity.
26.86%
Debt growth far above VUZI's 5.74%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.45%
R&D dropping or stable vs. VUZI's 30.93%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-11.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
